Navigation Links
INFORM® HPV

ProductsINFORM® HPV
Company Ventana Medical Systems Inc.
Item INFORM® HPV
Features Inquire
Description INFORM HPV allows the pathologist to visualize the presence of Human Papilloma Virus (HPV).

INFORM HPV allows testing on a choice of sample types: tissue, monolayer-based preparations, and conventional Pap.

INFORM HPV cocktails utilize proprietary probe formulations. The Family 16 probe cocktail has an affinity to HPV genotypes 16, 18, 31, 33, 35, 39, 51, 52, 56, 58, and 66. The Family 6 Probe cocktail has an affinity to HPV genotypes 6 and 11. INFORM HPV probes are manufactured under a validated process in order to ensure reproducible quality and staining characteristics.

Info Ventana Medical Systems Inc.
Customer Service: (800) 227-2155
Web site: http://www.ventanamed.com/

Related medicine products :

1. Hybrid Fixator
2. Hybrid Fixation System
3. Periarticular Hybrid Fixator
4. Hoffmann® II Hybrid
5. Hybridization Oven/Shaker 100 V, 60 Hz
6. PersonalHyb Hybridization Oven, 100/120V
7. PersonalHyb Hybridization Oven, 230V
8. Hybridization Oven (110 V)
9. Maxi 14 Hybridization Oven
10. Hybridization Oven (220 V)
11. Maxi XL Hybridization Oven
TAG: INFORM reg HPV
Breaking Medicine Technology:Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 1Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 2Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 3Clarient Reports Second Quarter Revenue Up 40 Percent 53673 1Clarient Reports Second Quarter Revenue Up 40 Percent 53673 2Clarient Reports Second Quarter Revenue Up 40 Percent 53673 3Clarient Reports Second Quarter Revenue Up 40 Percent 53673 4Clarient Reports Second Quarter Revenue Up 40 Percent 53673 5Clarient Reports Second Quarter Revenue Up 40 Percent 53673 6Clarient Reports Second Quarter Revenue Up 40 Percent 53673 7Clarient Reports Second Quarter Revenue Up 40 Percent 53673 8Clarient Reports Second Quarter Revenue Up 40 Percent 53673 9Clarient Reports Second Quarter Revenue Up 40 Percent 53673 10Cambrex Reports Second Quarter 2009 Results 53671 1Cambrex Reports Second Quarter 2009 Results 53671 2Cambrex Reports Second Quarter 2009 Results 53671 3Cambrex Reports Second Quarter 2009 Results 53671 4Cambrex Reports Second Quarter 2009 Results 53671 5Cambrex Reports Second Quarter 2009 Results 53671 6Cambrex Reports Second Quarter 2009 Results 53671 7Cambrex Reports Second Quarter 2009 Results 53671 8Cambrex Reports Second Quarter 2009 Results 53671 9Cambrex Reports Second Quarter 2009 Results 53671 10Cambrex Reports Second Quarter 2009 Results 53671 11Cambrex Reports Second Quarter 2009 Results 53671 12